Kierdaszuk Biruta, Jamrozik Zygmunt, Tońska Katarzyna, Bartnik Ewa, Kaliszewska Magdalena, Kamińska Anna, Kwieciński Hubert
Klinika Neurologii, Warszawski Uniwersytet Medyczny, 02-097 Warszawa.
Neurol Neurochir Pol. 2009 May-Jun;43(3):216-27.
Mitochondrial cytopathies are heterogeneous disorders affecting multiple systems but most commonly involving the skeletal muscle and central nervous system. The variety of symptoms and signs requires biochemical, morphological and genetic evaluation. The results of genetic studies indicate that there is no direct correlation between genotype and phenotype in mitochondrial cytopathies. This study is the first such analysis of a group of Polish patients with mitochondrial cytopathies. Its aim is to define the clinical features of mitochondrial cytopathies in relation to their genetic defects.
In a retrospective study, 46 patients with final diagnosis of mitochondrial cytopathy were evaluated clinically and electrophysiologically. Each patient underwent electromyography, electroneurography, and some patients were also assessed using electroencephalography. Clinical diagnoses were confirmed through the histopathological evaluation of muscle biopsies. In 36 cases mitochondrial DNA (mtDNA) testing was performed.
Eight different clinical syndromes were diagnosed among the evaluated patients. In the skeletal muscle biopsy, ragged-red fibres, which are a significant symptom for these disorders, were present in the majority of cases (93%). The presence of specific gene mutations was confirmed in 9 out of the 36 cases in which mtDNA was examined.
The results of our study confirm the remarkable clinical heterogeneity of mitochondrial cytopathies. Final diagnosis in many cases could only be confirmed by detection of the genetic defects. Molecular diagnosis may in the future have a significant impact on new therapeutic approaches.
线粒体细胞病是一类影响多个系统的异质性疾病,但最常累及骨骼肌和中枢神经系统。其症状和体征多样,需要进行生化、形态学和遗传学评估。遗传学研究结果表明,线粒体细胞病的基因型与表型之间没有直接关联。本研究是对一组波兰线粒体细胞病患者的首次此类分析。其目的是确定线粒体细胞病的临床特征与其遗传缺陷之间的关系。
在一项回顾性研究中,对46例最终诊断为线粒体细胞病的患者进行了临床和电生理评估。每位患者均接受了肌电图、神经电图检查,部分患者还进行了脑电图检查。通过肌肉活检的组织病理学评估证实临床诊断。对36例患者进行了线粒体DNA(mtDNA)检测。
在评估的患者中诊断出8种不同的临床综合征。在骨骼肌活检中,多数病例(93%)出现了这类疾病的一个显著症状——破碎红纤维。在接受mtDNA检测的36例病例中,有9例证实存在特定基因突变。
我们的研究结果证实了线粒体细胞病显著的临床异质性。在许多病例中,只有通过检测遗传缺陷才能确诊。分子诊断未来可能会对新的治疗方法产生重大影响。